Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?
Petra VinklerováPetra OvesnáMarkéta BednaříkováLuboš MinářMichal FelsingerJitka HausnerováVit WeinbergerPublished in: Cancers (2021)
The symptomatic endometrial cancer patients risk factor of earlier recurrence and death is insignificantly higher when compared with the asymptomatic cohort. However, multivariable analysis verifies that prognosis worsens with other clinically relevant parameters, not by symptomatology itself. In terms of survival outcome in EC patients, we recognized symptomatology as a non-significant marker for the patient's prognosis.